Last news
CI Labs Launches Singapore's First Homegrown Pharmacopoeia-Grade, Traditional-Medicine-Inspired Eczema Relief Cream, Offering a Gentle, Non-Steroidal Option for Sensitive Skin

CI Labs Launches Singapore's First Homegrown Pharmacopoeia-Grade, Traditional-Medicine-Inspired Eczema Relief Cream, Offering a Gentle, Non-Steroidal Option for Sensitive Skin

Formulated with 12 pharmacopoeia-grade botanicals, the new cream is designed to support eczema-prone and sensitive skin for young children and adults seeking a non-steroidal option. SINGAPORE, Jan. 26, 2026 /PRNewswire/ -- CI Labs, a Singapore-based...

AXA Completes Re-domiciliation to Hong Kong

AXA Completes Re-domiciliation to Hong Kong

HONG KONG, Jan. 26, 2026 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") is pleased to announce the successful completion of the re-domiciliation of AXA China Region Insurance Company (Bermuda) Limited ("the Company") from Bermuda to Hong Kong,...

AI-driven observability shortens MTTR by up to 70%, resulting a 15%-35% reduction in total IT operations cost

AI-driven observability shortens MTTR by up to 70%, resulting a 15%-35% reduction in total IT operations cost

SINGAPORE, Jan. 26, 2026 /PRNewswire/ -- Most enterprises believe they have observability because they have dashboards. In reality, IT teams are still operating with blind spots across critical systems, leading to slower incident response and...

Tulip Innovation Patent Claims Against Sunwoda Batteries Expand to Include KTC Action

Tulip Innovation Patent Claims Against Sunwoda Batteries Expand to Include KTC Action

BUDAPEST, Hungary, Jan. 26, 2026 /PRNewswire/ -- On 19 January 2026, the Korea Trade Commission (KTC) instituted a case based on claims filed by Tulip Innovation that Sunwoda's lithium-ion battery cells and Geely Auto Group's battery packs -...

Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes

Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes

-Topline data from the Phase II study for the treatment of diabetes are expected in the third quarter of 2026. -ASC30 d emonstrated p lacebo- a djusted w eight l oss of up to 7.7% in a recently completed 13- w eek U.S. P hase II s tudy in p...

Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard

Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard

TIANJIN, China, Jan. 26, 2026 /PRNewswire/ -- In a landmark move for the cell therapy industry, a Device Master File (DMF) describing the first dedicated quality control standard for Mesenchymal Stromal Cells (MSCs) was accepted by the U.S. Food and...

The Billion Dollar Brushstroke: Attorney's art platform secures $1B+ in committed listings in first month - positioned for rapid growth.

The Billion Dollar Brushstroke: Attorney's art platform secures $1B+ in committed listings in first month - positioned for rapid growth.

DUBAI, UAE, SYDNEY and NEW DELHI, Jan. 26, 2026 /PRNewswire/ -- An entertainment and creative arts lawyer's bold vision for a revolutionary online art auction platform, Lloyds Auctions, launched on January 1, 2026, and has already secured over $1...

DPC Dash-Domino's Pizza China Hits Symbolic Milestone: 1,405th Store Opens in Sanya, Matching Its HKEX Stock Ticker

DPC Dash-Domino's Pizza China Hits Symbolic Milestone: 1,405th Store Opens in Sanya, Matching Its HKEX Stock Ticker

HONG KONG, Jan. 26, 2026 /PRNewswire/ -- Domino's Pizza China ("DPC Dash" or the "Company") (1405.HK), the exclusive master franchisee for Domino's Pizza in the Chinese Mainland, Hong Kong SAR, and Macau SAR, today announced the opening of its...

1 ... 75 76 77 78 79 80 81 82 83 ... 3671
menu
menu